TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
-8.06%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$141M
AUM Growth
+$141M
(-55%)
Cap. Flow
-$163M
Cap. Flow
% of AUM
-115.14%
Top 10 Holdings %
Top 10 Hldgs %
60.47%
Holding
45
New
10
Increased
2
Reduced
14
Closed
14
Top Buys
| 1 |
Gilead Sciences
GILD
|
$7.16M |
| 2 |
Labcorp
LH
|
$6.55M |
| 3 |
HIND
Vyome Holdings, Inc. Common Stock
HIND
|
$4.98M |
| 4 |
Amgen
AMGN
|
$4.53M |
| 5 |
ATHN
Athenahealth, Inc.
ATHN
|
$4.31M |
Top Sells
| 1 |
ELGX
Endologix Inc
ELGX
|
$35.7M |
| 2 |
PDCO
Patterson Companies, Inc.
PDCO
|
$24.7M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
$18.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$16M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$12.4M |
Sector Composition
| 1 | Healthcare | 92.03% |
| 2 | Industrials | 3.05% |
| 3 | Consumer Discretionary | 2.51% |
| 4 | Communication Services | 0% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
1
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $10.6M | 7.48% | 850,000 -1,000,000 | -54% | -$12.4M |
|
|
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
| $9.64M | 6.82% | 367,690 -707,310 | -66% | -$18.5M |
|
3
Hologic
HOLX
$14.9B
| $9.23M | 6.53% | 230,000 -160,000 | -41% | -$6.42M |
|
4
Bio-Rad Laboratories Class A
BIO
$8.06B
| $8.93M | 6.32% | 49,000 -59,000 | -55% | -$10.8M |
|
5
Pacira BioSciences
PCRX
$1.2B
| $8.82M | 6.24% | 273,000 -127,000 | -32% | -$4.1M |
|
6
Jazz Pharmaceuticals
JAZZ
$7.75B
| $8.4M | 5.94% | 77,000 -23,000 | -23% | -$2.51M |
|
|
SPNC
7
DELISTED
Spectranetics Corp
SPNC
| $8.08M | 5.71% | 329,600 -170,400 | -34% | -$4.17M |
|
|
MDRX
8
DELISTED
Veradigm Inc. Common Stock
MDRX
| $7.81M | 5.53% | 765,000 -520,000 | -40% | -$5.31M |
|
|
9
Gilead Sciences
GILD
$140B
| $7.16M | 5.07% | +100,000 | New | +$7.16M |
|
10
Teladoc Health
TDOC
$1.37B
| $6.86M | 4.85% | 415,600 +90,600 | +28% | +$1.49M |
|
|
11
Labcorp
LH
$23.1B
| $6.55M | 4.63% | +51,000 | New | +$6.55M |
|
12
NovoCure
NVCR
$1.38B
| $6.48M | 4.58% | 825,000 +50,000 | +6% | +$392K |
|
|
CORV
13
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $5.04M | 3.56% | 1,825,000 -375,000 | -17% | -$1.04M |
|
|
HIND
14
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $4.98M | 3.52% | +562,606 | New | +$4.98M |
|
|
15
Amgen
AMGN
$155B
| $4.53M | 3.21% | +31,000 | New | +$4.53M |
|
16
Alkermes
ALKS
$4.78B
| $4.34M | 3.07% | 78,000 -147,000 | -65% | -$8.17M |
|
|
ATHN
17
DELISTED
Athenahealth, Inc.
ATHN
| $4.31M | 3.05% | +41,000 | New | +$4.31M |
|
18
Steris
STE
$24.1B
| $4.25M | 3% | 63,000 -157,000 | -71% | -$10.6M |
|
19
Service Corp International
SCI
$11.1B
| $3.55M | 2.51% | +125,000 | New | +$3.55M |
|
|
IPXL
20
DELISTED
Impax Laboratories, Inc.
IPXL
| $3.41M | 2.41% | +257,500 | New | +$3.41M |
|
|
CORI
21
DELISTED
Corium International, Inc.
CORI
| $2.99M | 2.12% | 737,242 -327,758 | -31% | -$1.33M |
|
|
LMNX
22
DELISTED
Luminex Corp
LMNX
| $2.73M | 1.93% | 135,000 -325,000 | -71% | -$6.57M |
|
|
STRM
23
DELISTED
Streamline Health Solutions
STRM
| $1.42M | 1.01% | 1,138,000 | – | – |
|
24
Boston Scientific
BSX
$156B
| $635K | 0.45% | +2,200 | New | +$635K |
|
|
QTNT
25
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $484K | 0.34% | 100,000 -650,000 | -87% | -$3.15M |
|